4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-129463
Chief R&D Officer sold 7,785 shares at $1.01 ($7,863)
From the SEC's structured data for this filing
Trades in this filing
Zalevsky Jonathan · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-19 | Sale : show line 1 in the form | −7,785 | $1.01 | $7,863 | 243,019 | D |
| Open-market sales · 7,785 sh · avg $1.01 · $7,863 | ||||||
Loading xslF345X05/ownership.xml…